Relmada Therapeutics, Inc. (RLMD) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.8
Day's range
$7.41

Relmada Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JUPITER TOPCO LLC 08/14/2026 11.16 M $77.32 M   100.00% 9.94%
BLACKROCK, INC. 08/07/2026 7.43 M $51.39 M   475.92% 6.61%
SQUADRON CAPITAL MANAGEMENT LLC 08/14/2026 7.35 M $50.86 M   -13.27% 6.54%
VR ADVISER, LLC 08/14/2026 6.84 M $47.36 M   41.31% 6.09%
SPRUCE STREET CAPITAL LP 08/13/2026 6.39 M $44.23 M   2.06% 5.69%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 4.76 M $32.96 M   0.00% 4.24%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 4.46 M $30.86 M   44.97% 3.97%
JONES HILL CAPITAL LP 08/13/2026 3.66 M $25.29 M   966.39% 3.25%
ORBIMED ADVISORS LLC 08/14/2026 3.63 M $25.13 M   -23.00% 3.23%
STATE STREET CORP 08/07/2026 2.52 M $17.42 M   605.12% 2.24%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.49 M $17.25 M   193.70% 2.22%
MILLENNIUM MANAGEMENT LLC 08/14/2026 2.36 M $16.34 M   -39.55% 2.10%
MARSHALL WACE, LLP 08/13/2026 2.25 M $15.55 M   -49.87% 2.00%
IKARIAN CAPITAL, LLC 08/14/2026 2.15 M $14.87 M   -20.09% 1.91%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 2.13 M $14.75 M   0.00% 1.90%
AMERIPRISE FINANCIAL INC 08/14/2026 1.94 M $13.41 M   21.81% 1.72%
EVENTIDE ASSET MANAGEMENT, LLC 08/14/2026 1.86 M $12.86 M   120.69% 1.65%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 1.52 M $10.52 M   502.36% 1.35%
STEMPOINT CAPITAL LP 08/14/2026 1.46 M $10.10 M   144.40% 1.30%
COMMODORE CAPITAL LP 08/14/2026 1.43 M $9.86 M   124.80% 1.27%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 1.34 M $9.28 M   -5.24% 1.19%
CITADEL ADVISORS LLC 09/02/2026 1.06 M $7.35 M   100.00% 0.94%
SIO CAPITAL MANAGEMENT, LLC 08/14/2026 1.00 M $6.94 M   4.00% 0.89%
OPALEYE MANAGEMENT INC. 08/14/2026 935.00 K $6.47 M   0.00% 0.83%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 898.20 K $6.22 M   100.00% 0.80%
GREAT POINT PARTNERS LLC 08/14/2026 842.11 K $5.83 M   0.00% 0.75%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 842.11 K $5.83 M   0.00% 0.75%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2026 842.11 K $5.83 M   0.00% 0.75%
BANK OF AMERICA CORP /DE/ 08/14/2026 812.06 K $5.62 M   544.79% 0.72%
NORTHERN TRUST CORP 08/13/2026 786.26 K $5.44 M   398.47% 0.70%
GOLDMAN SACHS GROUP INC 08/14/2026 767.62 K $5.31 M   9.81% 0.68%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 734.19 K $5.08 M   63.22% 0.65%
CI PRIVATE WEALTH, LLC 08/17/2026 719.58 K $4.93 M   0.00% 0.64%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 691.55 K $4.79 M   5.85% 0.62%
WALLEYE CAPITAL LLC 08/03/2026 616.24 K $4.26 M   100.00% 0.55%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 564.76 K $3.91 M   -22.54% 0.50%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 543.39 K $3.76 M   -23.74% 0.48%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 08/14/2026 500.00 K $3.46 M   11.11% 0.44%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 451.92 K $3.13 M   0.00% 0.40%
KNOTT DAVID M JR 08/12/2026 451.00 K $3.12 M   2.66% 0.40%
HIGHVISTA STRATEGIES LLC 08/14/2026 445.80 K $3.08 M   100.00% 0.40%
ADVISORSHARES INVESTMENTS LLC 08/11/2026 438.90 K $3.04 M   48.34% 0.39%
BIRCHVIEW CAPITAL, LP 08/14/2026 408.10 K $2.82 M   -0.31% 0.36%
DIADEMA PARTNERS LP 08/14/2026 361.37 K $2.50 M   79.93% 0.32%
PARSONS CAPITAL MANAGEMENT INC/RI 07/24/2026 354.07 K $2.45 M   0.45% 0.32%
SEVEN FLEET CAPITAL MANAGEMENT LP 08/17/2026 348.27 K $2.41 M   100.00% 0.31%
HARVEST INVESTMENT SERVICES, LLC 08/14/2026 340.89 K $2.36 M   100.00% 0.30%
WOODLINE PARTNERS LP 08/14/2026 328.42 K $2.27 M   -22.00% 0.29%
DEUTSCHE BANK AG\ 08/07/2026 318.90 K $2.21 M   41.83% 0.28%
SEVEN GRAND MANAGERS, LLC 08/14/2026 315.79 K $2.19 M   0.00% 0.28%

Relmada Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 170 institutional investors and hedge funds held shares of Relmada Therapeutics Inc. The most heavily invested institutionals were:

Jupiter Topco LLC: 11.16 M

BlackRock, Inc.: 7.43 M

Squadron Capital Management LLC: 7.35 M

VR Adviser, LLC: 6.84 M

Spruce Street Capital LP: 6.39 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 4.76 M

90.09% of Relmada Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 115.47 M shares in the last 24 months. This purchase volume represents approximately $827.93 M in transactions.